Current Insights in Murine Models for Breast Cancer: Present, Past and Future

Title:Current Insights in Murine Models for Breast Cancer: Present, Past and Future

Volume: 30 Issue: 29

Author(s): Mansi Jain and Anjana Goel*

Affiliation:

• Department of Biotechnology, GLA University, Mathura, India

Abstract: Breast cancer is an intricate disease that is increasing at a fast pace, and numerous heterogeneities within it further make it difficult to investigate. We have always used animal models to understand cancer pathology and create an in vivo microenvironment that closely resembles human cancer. They are considered an indispensable part of any clinical investigation regarding cancer. Animal models have a high potency in identifying the relevant biomarkers and genetic pathways involved in the course of disease prognosis. Researchers have previously explored a variety of organisms, including Drosophila melanogaster, zebrafish, and guinea pigs, to analyse breast cancer, but murine models have proven the most comprehensive due to their homologous nature with human chromosomes, easy availability, simple gene editing, and high adaptability. The available models have their pros and cons, and it depends on the researcher to select the one most relevant to their research question. Chemically induced models are cost-effective and simple to create. Transplantation models such as allografts and xenografts can mimic the human breast cancer environment reliably. Genetically engineered mouse models (GEMMs) help to underpin the genetic alterations involved and test novel immunotherapies. Virus-mediated models and gene knockout models have also provided new findings regarding breast cancer progression and metastasis. These mouse models have also enabled the visualization of breast cancer metastases. It is also imperative to consider the cost-effectiveness of these models. Despite loopholes, mouse models have evolved and are required for disease analysis.

Cite this article as:

Jain Mansi and Goel Anjana*, Current Insights in Murine Models for Breast Cancer: Present, Past and Future, Current Pharmaceutical Design 2024; 30 (29) . https://dx.doi.org/10.2174/0113816128306053240604074142